Rubicon Organics Appoints Glen Ibbott as Interim CFO

LOS ANGELES- Rubicon Organics Inc.  a Canadian producer of certified organic cannabis products, has appointed Glen Ibbott as Interim Chief Financial Officer, effective May 15, 2025. This leadership change follows the departure of Janis Risbin from her full-time role; she will remain in an advisory capacity during the transition period.

Glen Ibbott brings over 25 years of financial leadership experience in publicly traded life sciences and cannabis companies. He is notably recognized for his tenure as CFO at Aurora Cannabis Inc. from 2017 to 2024, where he contributed to the company’s growth and international expansion. Prior to his role at Aurora, Ibbott held senior finance positions at several healthcare and pharmaceutical firms, including QLT Inc., where he played a role in its $500 million merger with Aegerion Pharmaceuticals. He holds dual CPA designations in Canada and the U.S., as well as MBAs from Cornell University and Queen’s University.

Rubicon Organics’ CEO, Margaret Brodie, stated that Ibbott’s appointment comes at a pivotal time as the company scales new capacity and explores new markets for its premium cannabis brands. She acknowledged Risbin’s contributions since 2019 and expressed gratitude for her continued support during the transition.